Company / Return on Equity (ROE)
Protara Therapeutics, Inc. Return on Equity (ROE) History
FY2016-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-4.0%
FY2016
5-year range
-4.0% / -4.0%
FY2016-FY2016
Trend
-
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-4.0% in FY2016.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.74 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2016 | -4.0% | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026